[Priority setting of clinical preventive services for benefits extension]

Ko MJ, Kim YJ, Park J, An JH, Kim J, Baek Y, Yun YD, Lee SM
Record ID 32014001102
Korean
Original Title: 보장성 강화를 위한 예방의료서비스의 우선순위 개발
Authors' recommendations: Priority orders and its evaluation index for future clinical preventive services were studied in this research. As a result, clinical effectiveness, and cost effectiveness were the highest priority, followed by medical seriousness, applicable subjects, and public acceptance. Index for the clinical effectiveness were clinical index improvement and health behaviour; QALY, CE ratio for cost effectiveness; death rate and prevalence rate for medical seriousness; recommended age of population for applicable subjects; and lastly, requirements for public acceptance. With such base, drug treatment and educational counselling for smoking, educational counselling for obesity, counselling and analysis of nutritional intake are considered the major priorities for the clinical preventive services, especially for smoking. As the first step towards the extended benefits of clinical preventive services in the future, the analysis of the results has definite limitations. Standard index deriving from current treatment services, it should be acknowledged that such treatments may lack in preventive characteristic results from Korea, there were definite limitations to standardize the results; especially standardization of educational counselling and limited reference of cost effectiveness evidence. Insurance should be provided for services that are of high need and which have verified effects and disease control programs should be developed to increase the sustainability of chronic disease controls and support health promotion.
Details
Project Status: Completed
Year Published: 2014
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: South Korea
MeSH Terms
  • Preventive Health Services
Contact
Organisation Name: National Evidence-based healthcare Collaborating Agency
Contact Address: National Evidence-based Healthcare Collaborating Agency (NECA), 3~5F Health and Welfare Social Administration B/D, 400 Neungdong-ro, Gwangjin-gu, Seoul, Korea.
Contact Name: int@neca.re.kr
Contact Email: int@neca.re.kr
Copyright: National Evidence-based Healthcare Collaborating Agency (NECA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.